Clinical Trials in Seoul, Seoul
119 recruiting
Showing 1–20 of 88 trials
Recruiting
Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals454 enrolled94 locationsNCT06510374
Recruiting
Phase 3
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Ferring Pharmaceuticals250 enrolled73 locationsNCT06545955
Recruiting
Not Applicable
OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts
Myocardial InfarctionST Elevation Myocardial Infarction
Chonnam National University Hospital1,500 enrolled18 locationsNCT06227754
Recruiting
Phase 3
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals220 enrolled15 locationsNCT06858319
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals5,700 enrolled492 locationsNCT07517263
Recruiting
Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart FailureAcute Heart Failure
Colorado Prevention Center5,200 enrolled299 locationsNCT06008197
Recruiting
Phase 2
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Ovarian NeoplasmsUterine Cervical NeoplasmsEndometrial Neoplasms+3 more
Yonsei University198 enrolled27 locationsNCT06023862
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals500 enrolled16 locationsNCT06785818
Recruiting
Not Applicable
Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker
Heart FailureBradycardia
Samsung Medical Center106 enrolled1 locationNCT07563153
Recruiting
Phase 3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Novartis Pharmaceuticals106 enrolled127 locationsNCT05755386
Recruiting
Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
Breast Cancer FemaleBreast Reconstruction
DOF Inc.120 enrolled1 locationNCT06555614
Recruiting
Comparison of Acoustic Variability Index (AVI) and Pulse Pressure Variation (PPV) for Predicting Fluid Responsiveness in Mechanically Ventilated Patients
Hemodynamic MonitoringAnesthesia GeneralFluid Responsiveness Predictability
Signal House Co., Ltd.122 enrolled1 locationNCT07516470
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled58 locationsNCT07102628
Recruiting
Phase 1
To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers
Healthy
JW Pharmaceutical104 enrolled1 locationNCT07514780
Recruiting
Not Applicable
Routine Probe Compression After Transrectal Prostate Biopsy(RPCAB) to Reduce Bleeding and Infectious Complications : A Randomized Controlled Trial
Prostate BiopsyTRANSRECTAL ULTRASOUND-GUIDED PROSTATE BIOPSYPost Biopsy Bleeding
Veterans Health Service Medical Center, Seoul, Korea324 enrolled1 locationNCT07550985
Recruiting
Phase 2
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
Ovarian CancerOvarian Cancer Metastatic RecurrentOvarian Cancer (OvCa)+1 more
Yonsei University116 enrolled1 locationNCT07340164
Recruiting
Asciminib RMP Study
Chronic Myeloid Leukemia
Novartis Pharmaceuticals600 enrolled17 locationsNCT05943522
Recruiting
Phase 3
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerHER2-Negative Breast Carcinoma+2 more
Olema Pharmaceuticals, Inc.1,000 enrolled85 locationsNCT07085767
Recruiting
Phase 3
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
Non-small Cell Lung CancerBrain Tumor
InSightec30 enrolled10 locationsNCT05317858